Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| AdventHealth | OTHER |
Not provided
Not provided
Not provided
Not provided
The primary aim of this study is to test feasibility of a modified REACH II intervention in an outpatient clinic.
Primary Aim The primary aim of this study is to test feasibility of a modified REACH II intervention in an outpatient clinic.
Hypothesis:
The FL REACH intervention can be implemented reliably in this setting, with fidelity to the model and minimal burden on existing clinic structure.
Secondary Aims Aim 2: Examine the effectiveness of a REACH II translation in an outpatient setting.
Hypotheses:
CG disease knowledge will increase from pre-assessment to post-assessment.
Caregiver preparedness for caregiving will increase from pre-assessment to post-assessment.
Perceived risk by CG (CR access to dangerous objects + smoking + supervision + wandering + driving + screaming + desire to hit) will be reduced from pre-assessment to post-assessment.
Caregivers will demonstrate mastery of skill acquisition related to behavior change strategies.
Caregiver burden will decrease from pre-assessment to post-assessment.
Caregiver self-rated health will improve from pre-assessment to post-assessment.
Caregivers will have initiated the process of advanced care planning by the end of the intervention.
All measures will maintain gain in the anticipated direction from baseline measures at 6 months post-assessment.
Aim 3: Identify possible moderators of outcome, such as race/ethnicity, language, dosage or relationship.
This Aim is exploratory. Based in previous evidence, we estimate similar outcomes for all participants regardless of demographic factors, but previous trials have never been attempted in this novel setting. We will examine the data for differential outcomes related to such factors.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Group | Experimental | Participants will complete the FL-REACH annualized caregiver intervention. |
|
| Control Group | No Intervention | No-intervention control group |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FL-REACH | Behavioral | The FL REACH intervention is a 6-session intervention designed to facilitate transition to care following delivery of a memory disorders diagnosis by a MDC team. The intervention focused on an approach that used a toolbox of strategies to tailor skills-based learning, knowledge transmission, and self-care strategies to dementia caregivers. This pilot study focuses on adapting the established REACH II intervention for translation to the clinical setting, with a focus not only on implementation of the key components of the program, but also on feasibility and sustainability. This is part of a stepped-care model that is being developed at the AdventHealth-Orlando MDC. Caregivers of patients will be referred to the FL REACH intervention for foundational training and skills-development. |
| Measure | Description | Time Frame |
|---|---|---|
| Caregiver Burden | Zarit Burden Inventory | Baseline; 6 weeks (therapy termination); 6 month follow-up |
| Preparedness for Caregiving Measure | Preparedness for dementia caregiving | Baseline, session 2, 4, 6 (therapy termination); 6 month follow-up |
| Alzheimer's disease Knowledge Scale | Knowledge of Alzheimers Disease and Related Dementias | Baseline, 6 (therapy termination); 6 month follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Risk Assessment | FL-REACH Risk assessment | Baseline, 6 (therapy termination); 6 month follow-up |
| FL-REACH Satisfaction Survey | FL-REACH Satisfaction Survey. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| AdventHealth | Orlando | Florida | 32803 | United States | ||
| University of Central Florida |
There is no plan to share IPD at this time.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D003704 | Dementia |
| D008569 | Memory Disorders |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
Not provided
Not provided
Dementia caregivers were recruited initially. When dementia caregiver recruitment was completed, a small control group was recruited.
Not provided
Not provided
Not provided
Not provided
|
| Baseline, 6 (therapy termination); 6 month follow-up |
| Health Self-Report | Self-Report of personal health | Baseline, 6 (therapy termination); 6 month follow-up |
| Orlando |
| Florida |
| 32816 |
| United States |
| D019636 |
| Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |